(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (JJ new) (NN method)) (PP (IN for) (NP (NML (NN breast) (NN cancer)) (NN screening)))) (PP (IN from) (NP (NNP DCE) (HYPH -) (NNP MRI))) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ post-hoc) (NN approach)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN trained) (S (VP (VBG using) (ADVP (RB weakly)) (NP (NP (VBN annotated) (NNS data)) (-LRB- -LRB-) (S (ADVP (FW i.e.)) (, ,) (NP (NNS labels)) (VP (VBP are) (ADJP (JJ available) (PP (ADVP (RB only)) (IN at) (NP (DT the) (NN image) (NN level)))) (PP (IN without) (NP (DT any) (NN lesion) (NN delineation))))) (-RRB- -RRB-)))))))))))) (. .))
(NP (NP (PRP$ Our) (VBN proposed) (NML (FRAG (NP (JJ post-hoc) (NN method)) (ADVP (RB automatically)))) (NN diagnosis)) (NP (NP (NP (DT the) (JJ whole) (NN volume)) (CC and) (, ,) (PP (IN for) (NP (JJ positive) (NNS cases)))) (, ,) (SBAR (S (NP (PRP it)) (VP (VBZ localizes) (NP (NP (DT the) (JJ malignant) (NNS lesions)) (SBAR (WHNP (WDT that)) (S (VP (VBD led) (PP (IN to) (NP (JJ such) (NN diagnosis))))))))))) (. .))
(S (S (ADVP (RB Conversely)) (, ,) (NP (JJ traditional) (NNS approaches)) (VP (VBP follow) (NP (NP (DT a) (JJ pre-hoc) (NN approach)) (SBAR (WHNP (WDT that)) (S (ADVP (RB initially)) (VP (VBZ localises) (NP (NP (JJ suspicious) (NNS areas)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB subsequently)) (VP (VBN classified) (S (VP (TO to) (VP (VB establish) (NP (DT the) (NN breast) (NN malignancy)))))))))))))))) (: --) (S (NP (DT this) (NN approach)) (VP (VBZ is) (VP (VBN trained) (S (VP (VBG using) (ADVP (RB strongly)) (NP (NP (VBN annotated) (NNS data)) (-LRB- -LRB-) (S (ADVP (FW i.e.)) (, ,) (NP (PRP it)) (VP (VBZ needs) (NP (NP (DT a) (NN delineation) (CC and) (NN classification)) (PP (IN of) (NP (NP (DT all) (NNS lesions)) (PP (IN in) (NP (DT an) (NN image)))))))) (-RRB- -RRB-))))))) (. .))
(S (NP (NP (DT Another) (NN goal)) (PP (IN of) (NP (DT this) (NN paper)))) (VP (VBZ is) (S (VP (TO to) (VP (VB establish) (NP (NP (DT the) (NNS advantages) (CC and) (NNS disadvantages)) (PP (IN of) (NP (DT both) (NNS approaches)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN applied) (PP (IN to) (NP (NN breast) (NN screening))) (PP (IN from) (NP (NNP DCE) (HYPH -) (NNP MRI)))))))))) (. .))
(S (S (VP (VBG Relying) (PP (IN on) (NP (NP (NNS experiments)) (PP (IN on) (NP (NP (DT a) (NN breast) (NML (NNP DCE) (HYPH -) (NNP MRI)) (NN dataset)) (SBAR (WHNP (WDT that)) (S (VP (VBZ contains) (NP (NP (NNS scans)) (PP (IN of) (NP (CD 117) (NNS patients))))))))))))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (JJ post-hoc) (NN method)) (VP (VBZ is) (ADJP (RBR more) (JJ accurate) (PP (IN for) (S (VP (VP (VBG diagnosing) (NP (NP (DT the) (JJ whole) (NN volume)) (PP (IN per) (NP (NN patient))))) (, ,) (VP (VBG achieving) (NP (NP (DT an) (NN AUC)) (PP (IN of) (NP (CD 0.91))))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ pre-hoc) (NN method)) (VP (VBZ achieves) (NP (NP (DT an) (NN AUC)) (PP (IN of) (NP (CD 0.81))))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN performance)) (PP (IN for) (S (VP (VBG localising) (NP (DT the) (JJ malignant) (NNS lesions)))))) (VP (VBZ remains) (ADJP (JJ challenging) (PP (IN for) (NP (DT the) (JJ post-hoc) (NN method)))) (PP (IN due) (IN to) (NP (NP (DT the) (ADJP (RB weakly) (VBN labelled)) (NN dataset)) (VP (VBN employed) (PP (IN during) (NP (NN training))))))) (. .))
